SERPINA1 Z allele is associated with cystic fibrosis liver disease

被引:25
作者
Boelle, Pierre-Yves [1 ]
Debray, Dominique [2 ,3 ]
Guillot, Loic [2 ]
Corvol, Harriet [2 ,4 ]
机构
[1] Sorbonne Univ, Hop St Antoine, AP HP, iPLESP,INSERM, Paris, France
[2] Sorbonne Univ, INSERM, CRSA, Paris, France
[3] Hop Necker Enfants Malad, AP HP, Unit Hepatol Pediat, Paris, France
[4] Hop Trousseau, AP HP, Serv Pneumol Pediat, Paris, France
关键词
SERPINA1; Z; cystic fibrosis; liver disease; cirrhosis; portal hypertension; GENE;
D O I
10.1038/s41436-019-0449-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: The SERPINA1 Z allele is associated with cystic fibrosis (CF)-related liver disease (CFLD), a common manifestation in patients with CF. We estimated CFLD incidence based on the SERPINAI genotype in 3328 CF patients with CFLD-phenotype information. Methods: The associations of SERPINA1 Z (rs28929474) and S (rs17580) alleles with age at CFLD onset and the development of CFLD-related complications (severe liver disease with cirrhosis, portal hypertension, esophageal varices) were analyzed. Results: Overall, 3% of patients carried the SERPINA1 Z allele and 13% carried the S allele. The cumulative incidence of CFLD increased more rapidly in patients carrying the Z allele (hazard ratio [HR] = 1.6; 95% confidence interval [CI] = 1.1-2.4, P = 0.019), reaching 47% by age 25 compared with 30% in noncarriers. Increased risk was similar for patients with severe CFLD (HR = 1.5, 95% CI = 0.7-3.2, P = 0.31) but failed to reach significance due to a limited sample size of Z-allele carriers. No significant effect was found for the S allele. Conclusion: CF patients carrying the SERPINA1 Z allele had an increased risk of developing CFLD and related complications compared with noncarriers. Routine SERPINA1 Z genotyping upon CF diagnosis is warranted for identifying patients worthy of closer liver disease monitoring.
引用
收藏
页码:2151 / 2155
页数:5
相关论文
共 19 条
[1]  
[Anonymous], 2017, COCHRANE DB SYST REV
[2]  
Bartels CL, 2009, AM J TRANSL RES, V1, P406
[3]   Genetic Modifiers of Liver Disease in Cystic Fibrosis [J].
Bartlett, Jaclyn R. ;
Friedman, Kenneth J. ;
Ling, Simon C. ;
Pace, Rhonda G. ;
Bell, Scott C. ;
Bourke, Billy ;
Castaldo, Giuseppe ;
Castellani, Carlo ;
Cipolli, Marco ;
Colombo, Carla ;
Colombo, John L. ;
Debray, Dominique ;
Fernandez, Adriana ;
Lacaille, Florence ;
Macek, Milan, Jr. ;
Rowland, Marion ;
Salvatore, Francesco ;
Taylor, Christopher J. ;
Wainwright, Claire ;
Wilschanski, Michael ;
Zemkova, Dana ;
Hannah, William B. ;
Phillips, M. James ;
Corey, Mary ;
Zielenski, Julian ;
Dorfman, Ruslan ;
Wang, Yunfei ;
Zou, Fei ;
Silverman, Lawrence M. ;
Drumm, Mitchell L. ;
Wright, Fred A. ;
Lange, Ethan M. ;
Durie, Peter R. ;
Knowles, Michael R. ;
Clancy, J. P. ;
Sindel, L. J. ;
Roberts, D. M. ;
Roberts, V. ;
Radford, P. J. ;
Argel, N. ;
Morgan, W. J. ;
Douthit, J. L. ;
Schellhase, D. E. ;
Anderson, P. ;
Taggart, A. ;
Morrissey, B. ;
Platzker, A. C. G. ;
Woo, M. S. ;
Fukushima, L. ;
Hsu, E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (10) :1076-1083
[4]  
Boelle PY, 2018, HEPATOLOGY, V30
[5]   Cystic fibrosis genetics: from molecular understanding to clinical application [J].
Cutting, Garry R. .
NATURE REVIEWS GENETICS, 2015, 16 (01) :45-56
[6]   Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives [J].
Debray, Dominique ;
Narkewicz, Michael R. ;
Bodewes, Frank A. J. A. ;
Colombo, Carla ;
Housset, Chantal ;
de Jonge, Hugo R. ;
Jonker, Johan W. ;
Kelly, Deirdre A. ;
Ling, Simon C. ;
Poynard, Thierry ;
Sogni, Philippe ;
Trauner, Michael ;
Witters, Peter ;
Baumann, Ulrich ;
Wilschanski, Michael ;
Verkade, Henkjan J. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 65 (04) :443-448
[7]   Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease [J].
Debray, Dominique ;
Kelly, Deirdre ;
Houwen, Roderick ;
Strandvik, Birgitta ;
Colombo, Carla .
JOURNAL OF CYSTIC FIBROSIS, 2011, 10 :S29-S36
[8]   Rank invariant tests for interval censored data under the grouped continuous model [J].
Fay, MP .
BIOMETRICS, 1996, 52 (03) :811-822
[9]   Lung disease modifier genes in cystic fibrosis [J].
Guillot, Loic ;
Beucher, Julie ;
Tabary, Olivier ;
Le Rouzic, Philippe ;
Clement, Annick ;
Corvol, Harriet .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 52 :83-93
[10]   Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study [J].
McKone, EF ;
Emerson, SS ;
Edwards, KL ;
Aitken, ML .
LANCET, 2003, 361 (9370) :1671-1676